Guggulsterone, a farnesoid X receptor antagonist lowers plasma trimethylamine-
Animals
Anti-Inflammatory Agents
/ pharmacology
Antioxidants
/ pharmacology
Atherosclerosis
/ metabolism
Cardiotonic Agents
/ pharmacology
Choline
/ pharmacology
Clostridium
/ metabolism
Diet
Escherichia
/ metabolism
Hypolipidemic Agents
/ pharmacology
Kidney
/ drug effects
Lipid Peroxidation
/ drug effects
Liver
/ drug effects
Methylamines
/ blood
Myocardium
/ metabolism
Pregnenediones
/ pharmacology
Rats, Wistar
Receptors, Cytoplasmic and Nuclear
/ antagonists & inhibitors
Guggulsterone
atherosclerosis
gut microbiota
trimethylamine
trimethylamine--oxide
Journal
Human & experimental toxicology
ISSN: 1477-0903
Titre abrégé: Hum Exp Toxicol
Pays: England
ID NLM: 9004560
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
pubmed:
12
12
2018
medline:
9
1
2020
entrez:
12
12
2018
Statut:
ppublish
Résumé
The current study investigated the role of guggulsterone (GS), a farnesoid X receptor antagonist, in the choline metabolism and its trimethylamine (TMA)/flavin monooxygenases/trimethylamine-
Identifiants
pubmed: 30526076
doi: 10.1177/0960327118817862
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Antioxidants
0
Cardiotonic Agents
0
Hypolipidemic Agents
0
Methylamines
0
Pregnenediones
0
Receptors, Cytoplasmic and Nuclear
0
farnesoid X-activated receptor
0C5V0MRU6P
pregna-4,17-diene-3,16-dione
A4PW148END
trimethyloxamine
FLD0K1SJ1A
trimethylamine
LHH7G8O305
Choline
N91BDP6H0X
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM